Pregnancy often causes complications for women with antiphospholipid syndrome (APS), in which their immune system produces antiphospholipid antibodies which interact with the body’s own cells. Women with antiphospholipid antibodies and APS have a much higher risk of preeclampsia, recurrent early pregnancy loss, intrauterine death and fetal growth restriction because the..
The Novo Nordisk Foundation has allocated DKK 2.4 billion (€322 million) for its Research Leader Programme aimed at excellent research leaders at different stages of their careers.
Individual grants of up to DKK 10 million are awarded each year. The 5-year grants are awarded within the scientific fields:
The grants are awarded based on applications submitted in open competition. Calls for applications are typically open in late fall with deadlines in January.
See all Novo Nordisk Foundation calls here.